Related Experiment Video
Updated: May 29, 2026

A Galleria mellonella Oral Administration Model to Study Commensal-Induced Innate Immune Responses
Published on: March 21, 2019
Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed
Inga-Maria Frick1, Sara L Nordin, Maria Baumgarten
1Section for Infection Medicine, Department of Clinical Sciences, Lund University, Skåne University Hospital, SE-221 85 Lund, Sweden.
Abstract:
Epithelial linings serve as physical barriers and produce antimicrobial peptides (AMPs) to maintain host integrity. Examples are the bactericidal proteins midkine (MK) and BRAK/CXCL14 that are constitutively produced in the skin epidermal layer, where the anaerobic Gram-positive coccoid commensal Finegoldia magna resides. Consequently, this bacterium is likely to encounter both MK and BRAK/CXCL14, making these molecules possible threats to its habitat. In this study, we show that MK expression is upregulated during inflammation, concomitant with a strong downregulation of BRAK/CXCL14, resulting in changed antibacterial conditions. MK, BRAK/CXCL14, and the inflammation-dependent antimicrobial β-defensins human β-defensin (hBD)-2 and hBD-3 all showed bactericidal activity against both F. magna and the virulent pathogen Streptococcus pyogenes at similar concentrations. SufA, a released protease of F. magna, degraded MK and BRAK/CXCL14 but not hBD-2 nor hBD-3. Cleavage was seen at lysine and arginine residues, amino acids characteristic of AMPs. Intermediate SufA-degraded fragments of MK and BRAK/CXCL14 showed stronger bactericidal activity against S. pyogenes than F. magna, thus promoting survival of the latter. In contrast, the cysteine-protease SpeB of S. pyogenes rapidly degraded all AMPs investigated. The proteins FAF and SIC, released by F. magna and S. pyogenes, respectively, neutralized the antibacterial activity of MK and BRAK/CXCL14, protein FAF being the most efficient. Quantitation and colocalization by immunoelectron microscopy demonstrated significant levels and interactions of the molecules in in vivo and ex vivo samples. The findings reflect strategies used by a permanently residing commensal and a virulent pathogen, the latter operating during the limited time course of invasive disease.
Insights
This study reveals how the skin bacterium Finegoldia magna survives antimicrobial peptides (AMPs) like midkine (MK) and BRAK/CXCL14. F. magna uses its protease SufA to degrade these AMPs, while also producing FAF to neutralize them, aiding its survival.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- Epithelial barriers produce antimicrobial peptides (AMPs) like midkine (MK) and BRAK/CXCL14 to maintain host defense.
- The skin commensal Finegoldia magna and the pathogen Streptococcus pyogenes inhabit environments rich in these AMPs.
- Inflammation alters the expression of MK and BRAK/CXCL14, impacting the local antimicrobial milieu.
Purpose of the Study:
- To investigate the interactions between F. magna, S. pyogenes, and host antimicrobial peptides (AMPs) in the skin.
- To determine the mechanisms by which F. magna survives exposure to MK and BRAK/CXCL14.
- To compare the strategies employed by a commensal and a pathogen in combating host defenses.
Main Methods:
- Bactericidal assays using MK, BRAK/CXCL14, human beta-defensins (hBD)-2, and hBD-3 against F. magna and S. pyogenes.
- Enzymatic degradation studies using F. magna protease SufA and S. pyogenes protease SpeB on AMPs.
- Neutralization assays using F. magna protein FAF and S. pyogenes protein SIC.
- Immunoelectron microscopy for quantitation and colocalization of molecules in biological samples.
Main Results:
- MK and BRAK/CXCL14, along with hBD-2 and hBD-3, exhibited bactericidal activity against both F. magna and S. pyogenes.
- F. magna's protease SufA degraded MK and BRAK/CXCL14, with fragments showing enhanced activity against S. pyogenes.
- F. magna's protein FAF and S. pyogenes' SpeB protease neutralized AMPs, with FAF being more effective; SpeB degraded all tested AMPs.
- Significant levels and interactions of these molecules were observed in vivo and ex vivo samples.
Conclusions:
- F. magna employs sophisticated strategies, including protease degradation and protein neutralization of host AMPs, to ensure its survival.
- The differential degradation and neutralization of AMPs by F. magna and S. pyogenes highlight distinct survival tactics.
- These findings provide insights into the complex interplay between commensal bacteria, pathogens, and host immune defenses in the skin microbiome.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Determinants of Bacterial Pathogenicity and Virulence
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing
